Overview

Definition: Chest wall resection and reconstruction is a complex surgical procedure involving the removal of a portion of the chest wall (ribs, intercostal muscles, pleura, and sometimes sternum or scapula) due to malignant or benign tumors, followed by restoration of chest wall integrity and function.
Epidemiology:
-Primary chest wall tumors are rare, accounting for less than 1% of all thoracic neoplasms
-Secondary involvement from contiguous structures (lung, breast, mediastinum) or distant metastases is more common
-Incidence varies based on tumor type
-chondrosarcomas and osteosarcomas are frequent primary bone tumors, while sarcomas and carcinomas are common soft tissue malignancies.
Clinical Significance:
-Effective management of chest wall tumors is crucial for local tumor control, palliation of symptoms (pain, dyspnea), and improving quality of life
-The complexity lies in achieving oncologic clearance while preserving respiratory mechanics and cosmesis, demanding multidisciplinary collaboration
-This is a challenging area for surgical trainees preparing for DNB and NEET SS exams.

Clinical Presentation

Symptoms:
-A palpable mass or swelling
-Localized chest pain, often worsening with respiration or movement
-Dyspnea or shortness of breath, especially with larger tumors or pleural involvement
-Cough
-Weight loss and fatigue in advanced stages
-Pathological fractures of ribs or sternum.
Signs:
-A visible or palpable chest wall mass
-Tenderness over the mass
-Skin changes over the mass (erythema, ulceration)
-Restricted chest wall expansion
-Crepitus if bone involvement
-Signs of pleural effusion or respiratory compromise.
Diagnostic Criteria:
-Diagnosis is primarily based on imaging and histopathology
-No specific clinical diagnostic criteria exist for chest wall tumors
-suspicion arises from clinical findings and is confirmed by investigations
-Management decisions are guided by staging and tumor characteristics, adhering to established oncologic principles for surgical resection margins.

Diagnostic Approach

History Taking:
-Detailed history of symptom onset and progression
-Presence of pain and its characteristics (location, intensity, aggravating/relieving factors)
-History of prior malignancy (lung, breast, melanoma)
-Family history of cancer
-Exposure history (radiation, occupational).
Physical Examination:
-Thorough palpation of the chest wall mass (size, consistency, mobility, tenderness)
-Assessment of overlying skin
-Examination of respiratory system for adventitious sounds or reduced breath sounds
-Evaluation of overall chest wall symmetry and respiratory excursion.
Investigations:
-Imaging: Chest X-ray (initial assessment, bony abnormalities)
-CT scan of the chest (precise tumor size, location, extent, relationship to adjacent structures, pleura, mediastinum, and bony involvement
-crucial for surgical planning)
-MRI of the chest (superior for soft tissue detail, nerve involvement, and marrow infiltration)
-PET-CT scan (staging, distant metastasis assessment, differentiating benign from malignant)
-Biopsy: Core needle biopsy or incisional biopsy under image guidance for histopathological diagnosis and grading
-Laboratory tests: Routine blood counts, liver and renal function tests, tumor markers (e.g., CEA, AFP, PSA, CA 125, if indicated based on suspected primary).
Differential Diagnosis:
-Benign bone tumors (osteochondroma, enchondroma)
-Benign soft tissue tumors (lipoma, fibroma)
-Infectious processes (empyema, osteomyelitis)
-Hematoma or seroma
-Metastatic disease to the chest wall from other primary sites
-Primary lung cancer invading the chest wall
-Breast cancer invading the chest wall
-Desmoid tumors
-Sarcoidosis.

Management

Indications:
-Complete resection for potentially curable primary malignant tumors
-Palliation of pain or respiratory compromise due to unresectable or symptomatic tumors
-Resection of large or symptomatic benign tumors causing mass effect or deformity.
Surgical Management:
-Surgical resection is the cornerstone for malignant chest wall tumors
-The goal is complete en bloc resection with wide negative margins (R0 resection)
-Techniques vary based on tumor location and extent: Rib resection (segmental or full-length)
-Sternectomy
-Scapulothoracic resection
-Reconstruction methods: Mesh (synthetic or biological) for small to moderate defects
-Local tissue flaps (pectoralis major, latissimus dorsi, rectus abdominis)
-Free flaps for extensive defects
-Prosthetic materials (methyl methacrylate, silicone).
Preoperative Preparation:
-Multidisciplinary team discussion (thoracic surgeon, surgical oncologist, plastic surgeon, medical oncologist, radiation oncologist, radiologist, pathologist)
-Detailed imaging review for surgical planning
-Optimization of cardiorespiratory status
-Nutritional assessment
-Psychosocial support
-Consent for extensive surgery and potential reconstruction.
Postoperative Care:
-Intensive care unit (ICU) monitoring
-Pain management (epidural, PCA, multimodal analgesia)
-Respiratory support (mechanical ventilation if needed, chest physiotherapy)
-Chest tube management
-Wound care and infection prevention
-Early mobilization
-Nutritional support
-Monitoring for complications.
Supportive Care:
-Palliation of pain and dyspnea
-Nutritional support to optimize healing
-Psychological support for patients and families
-Rehabilitation services
-Management of oncological treatments (chemotherapy, radiation therapy) in conjunction with surgical care.

Complications

Early Complications:
-Wound infection
-Flap necrosis
-Pneumothorax or hemothorax
-Respiratory failure or hypoventilation
-Pain
-Seroma or hematoma
-Chest wall instability and paradoxical motion
-Pleural effusion
-Chylothorax.
Late Complications:
-Chronic pain
-Chest wall deformity
-Adhesions and restrictive lung disease
-Recurrence of tumor
-Chronic respiratory compromise
-Graft infection or dehiscence
-Poor cosmesis.
Prevention Strategies:
-Meticulous surgical technique and hemostasis
-Adequate soft tissue coverage for mesh or prostheses
-Prophylactic antibiotics
-Judicious use of drains
-Chest physiotherapy and early mobilization
-Appropriate pain control
-Careful patient selection and optimization.

Prognosis

Factors Affecting Prognosis:
-Tumor type (benign vs
-malignant)
-Histological grade
-Stage of disease (TNM staging)
-Completeness of surgical resection (R0 vs
-R1/R2)
-Presence of lymph node metastasis
-Patient's overall health status and comorbidities
-Response to adjuvant therapy.
Outcomes:
-For benign tumors, resection generally leads to excellent outcomes with good functional recovery
-For malignant tumors, prognosis is highly variable and depends on the factors listed above
-Local recurrence rates are significant for inadequately resected tumors
-Survival rates are best for completely resected early-stage primary tumors
-For advanced or metastatic disease, prognosis is poorer.
Follow Up:
-Regular clinical examination and imaging (CT chest) are essential to detect local recurrence, regional spread, or distant metastases
-Follow-up intervals are typically every 3-6 months for the first 2-3 years, then annually
-Long-term surveillance is crucial, especially for malignant tumors
-Duration of follow-up depends on tumor biology and risk of recurrence.

Key Points

Exam Focus:
-DNB and NEET SS candidates must understand the indications for resection, principles of R0 resection, common reconstruction techniques (mesh, flaps), and management of chest wall instability
-Know the common types of chest wall tumors and their typical presentations.
Clinical Pearls:
-Preoperative imaging (CT chest with IV contrast) is paramount for precise surgical planning
-Multidisciplinary team approach is essential for optimal outcomes
-Reconstruction requires careful consideration of defect size, location, and patient factors to ensure respiratory function and cosmesis.
Common Mistakes:
-Inadequate resection margins leading to recurrence
-Underestimating the complexity of reconstruction
-Failure to adequately address respiratory mechanics and pain postoperatively
-Delay in diagnosis or referral
-Not considering the potential for distant metastasis in malignant lesions.